Autoimmune Diseases
Original Research
Oral Lichen Planus Treated With Plasma Rich in Growth Factors
The use of plasma rich in growth factors (PRGF) is a treatment for erosive oral lichen planus (OLP) resistant to steroid therapy.
Case Reports
Interstitial Granulomatous Dermatitis as an Adverse Reaction to Vedolizumab
Reactive granulomatous dermatitis, interstitial granulomatous dermatitis (IGD) type, can occur as an adverse reaction to vedolizumab despite the...
Conference Coverage
Real-world data reinforce stem cell transplant for progressive systemic sclerosis
In real-world study, stem cell transplant provides major advantages for rapidly progressive systemic sclerosis if strict selection criteria are...
Hospital Consult
Current Recommendations for the Systemic Treatment of Cutaneous Lupus Erythematosus During Pregnancy
Cutaneous lupus erythematosus (CLE) is a heterogeneous autoimmune disease of the skin that commonly affects women of childbearing age. We describe...
Photo Challenge
Diffuse Urticarial Rash in a Pregnant Patient
A 29-year-old pregnant woman at 18 weeks and 5 days of gestation presented with a diffuse, pruritic, blistering rash of 5 weeks’ duration that...
Latest News
Lilly calls it quits on baricitinib’s development for lupus
The company said it is stopping phase 3 trials because of disappointing results.
Feature
Rituximab and COVID-19 vaccines: Studies begin to answer key questions
This article aims to summarize the latest research on how rituximab affects humoral and cell-mediated response following a COVID-19 vaccine...
Make the Diagnosis
A 22-year-old presented with erythematous papules on her fingers and toes
A 22-year-old with a history of ITP presented with 2 months of asymptomatic erythematous papules on her fingers and toes.
Conference Coverage
Validity of commercial serologic tests for dermatomyositis still questionable
“The testing in research laboratories is not widely available and the results are often delayed by weeks to months.”
From the Journals
Prevalence of undiagnosed vitiligo is ‘remarkably high’
Current overall prevalence among adult population estimated at 1.9 million to 2.8 million in the United States.
Conference Coverage
Adding rituximab to belimumab offers no help for lupus
The combination of rituximab and belimumab was associated with a longer duration of response, but there was no benefit of belimumab alone for...